Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related Malignancies

6 May 2004

Abstract excerpt

Epstein-Barr Virus (EBV), a ubiquitous gamma herpes virus, infects more than 95% of the human population before adulthood. Life-long persistence, usually without adverse health consequences, relies on a balance between viral latency, viral replication, and host immune response. Patients with EBV-related disease often have high levels of EBV DNA in their plasma. This study addresses whether this circulating,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15167006
DOI: 10.1097/00019606-200406000-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related MalignanciesPMID 15167006Read ↗

The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseasesSemantic proximity Read ↗

Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV‐associated diseaseSemantic proximity Read ↗

Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's diseaseSemantic proximity Read ↗

Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.Semantic proximity Read ↗

Epstein-Barr virus (EBV) reactivation and therapeutic inhibitorsSemantic proximity Read ↗

Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCRSemantic proximity Read ↗

Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infectionSemantic proximity Read ↗

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In VivoSemantic proximity Read ↗

Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR AssaySemantic proximity Read ↗

Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinomaSemantic proximity Read ↗

Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated DiseasesSemantic proximity Read ↗

PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.